EPO Patent EP2026029509A1: Expression Cassette
Summary
The European Patent Office has published patent application EP2026029509A1 concerning an expression cassette comprising a Cyba-derived untranslated region and its use. The publication date is March 18, 2026, and the inventors have not yet filed their designation.
What changed
The European Patent Office (EPO) has published patent application EP2026029509A1, titled "EXPRESSION CASSETTE COMPRISING CYBA-DERIVED UNTRANSLATED REGION AND USE THEREOF." This publication, dated March 18, 2026, details a specific type of expression cassette relevant to biotechnology and pharmaceutical research.
This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations or deadlines on regulated entities. Companies operating in the biotechnology and pharmaceutical sectors may wish to review this patent for potential implications regarding intellectual property and research and development activities.
Source document (simplified)
EXPRESSION CASSETTE COMPRISING CYBA-DERIVED UNTRANSLATED REGION AND USE THEREOF
Publication EP2026029509A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C12N 15/67 20060101AFI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.